PrEP

Researchers from the VA system examined how mail-order delivery of drugs affects their patients with HIV.

Clinicians should screen all newly diagnosed HIV patients for tuberculosis.

Even macrophages aren’t safe from HIV.

Biologic HIV drug may reduce new infections among high risk populations.

A broadly neutralizing antibody was observed to reduce HIV viral load and prevent transmission.

New system could improve the implementation of pre-exposure prophylaxis-based care for HIV prevention.

Although PrEP is highly effective, few appropriate patients with HIV currently use it.

Statistics show condomless sex is on the rise among men who have sex with men.

Comorbid chronic obstructive pulmonary disorder may be underestimated in patients with HIV.

Top articles of the week on Specialty Pharmacy Times.

For patients with HIV, liver disease is a major cause of morbidity and mortality.

Social media can identify behavioral trends and attitudes relevant to the risk of infection with HIV.

While nephrotoxicity associated with TDF has been well documented, prospective studies in HIV patients have been lacking.

African American women account for 62% of women diagnosed with HIV.

Study examines whether sharing HIV status has an impact on depression or anxiety symptoms.

HIV non-disclosure not found to have an adverse impact on depression or anxiety symptoms.

Risky sexual behavior increases the rate of HIV transmission among at-risk populations.

Dementia is one of the most prevalent complications among patients with late-stage HIV.

Sale of Panretin gel tubes approved in the United States due to a drug shortage as a result of a manufacturing issue.

Naturally-occurring antibodies that fight HIV open new avenues for research.

Unprotected sexual exposure to HIV does not necessarily lead to infection.

Benefits of ART for maternal health and prevention of perinatal transmission outweigh risks in mothers with HIV.

HIV treatment guidelines typically do not address specific characteristics for gay, bisexual, and men who have sex with men.

National and global HIV guidelines recommend initiating antiretroviral therapy in all patients, regardless of CD4 count.

Low baseline vitamin D deficiency may decrease the effectiveness of rosuvastatin in adults with HIV.